RejuvenAir® System Trial for COPD With Chronic Bronchitis

NAActive, not recruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

July 9, 2020

Primary Completion Date

May 31, 2025

Study Completion Date

September 30, 2026

Conditions
Chronic Bronchitis
Interventions
DEVICE

RejuvenAir System

RejuvenAir Metered CryoSpray

DEVICE

Sham Control Procedure

Sham Control Procedure

Trial Locations (27)

16601

Clinical Research Associates of Central PA, Altoona

19140

Temple University - Of the Commonwealth System of Higher Education, Philadelphia

21201

University of Maryland, Baltimore

21287

Johns Hopkins Universtiy, Baltimore

27705

Duke University, Durham

29203

Prisma Health - Midlands, Columbia

29425

Medical University of South Carolina, Charleston

33470

Advanced Pulmonary Research Institute, Loxahatchee Groves

34239

Sarasota Memorial Hospital, Sarasota

43210

The Ohio State Universisty, Columbus

44195

The Cleveland Clinic Foundation, Cleveland

45267

University Of Cincinnati, Cincinnati

48202

Henry Ford Health System, Detroit

49503

Spectrum Health, Grand Rapids

53226

Medical College of Wisconsin, Milwaukee

53792

University of Wisconsin Hospital and Clinics, Madison

60611

Northwestern University, Chicago

71103

Louisiana State University Medical Center, Shreveport

75390

University of Texas Southwestern Medical Center, Dallas

78626

St. David's Georgetown Hospital, Georgetown

94040

El Camino Hospital, Mountain View

95817

University of California, Davis Medical Center, Sacramento

08258

Honor Health, Scottsdale

02215

Beth Israel Deaconess Medical Center, Boston

03756

Dartmouth-Hitchcock Medical Center, Lebanon

08103

Cooper Health System, Camden

SW3 6NP

The Royal Brompton Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CSA Medical, Inc.

INDUSTRY

NCT03893370 - RejuvenAir® System Trial for COPD With Chronic Bronchitis | Biotech Hunter | Biotech Hunter